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Melioidosis is a disease of humans and animals that is caused by the saprophytic bacterium Burkholderia pseudomallei.
Once thought to be confined to certain locations, the known presence of B. pseudomallei is expanding as more regions of ende-
micity are uncovered. There is no vaccine for melioidosis, and even with antibiotic administration, the mortality rate is as high
as 40% in some regions that are endemic for the infection. Despite high levels of recombination, phylogenetic reconstruction of
B. pseudomallei populations using whole-genome sequencing (WGS) has revealed surprisingly robust biogeographic separation
between isolates from Australia and Asia. To date, there have been no confirmed autochthonous melioidosis cases in Australia
caused by an Asian isolate; likewise, no autochthonous cases in Asia have been identified as Australian in origin. Here, we used
comparative genomic analysis of 455 B. pseudomallei genomes to confirm the unprecedented presence of an Asian clone, se-
quence type 562 (ST-562), in Darwin, northern Australia. First observed in Darwin in 2005, the incidence of melioidosis cases
attributable to ST-562 infection has steadily risen, and it is now a common strain in Darwin. Intriguingly, the Australian ST-562
appears to be geographically restricted to a single locale and is genetically less diverse than other common STs from this region,
indicating a recent introduction of this clone into northern Australia. Detailed genomic and epidemiological investigations of
new clinical and environmental B. pseudomallei isolates in the Darwin region and ST-562 isolates from Asia will be critical for
understanding the origin, distribution, and dissemination of this emerging clone in northern Australia.
The Gram-negative soil-dwelling bacterium Burkholderia pseu-domallei is the etiologic agent of melioidosis, an often deadly
tropical disease that can be difficult to diagnose, particularly in
nonendemic or resource-poor regions where cases are not ex-
pected and appropriate microbiological diagnostic tools are not
readily available (1). Diabetics are particularly susceptible to me-
lioidosis. B. pseudomallei infection can be acquired from contam-
inated soil or water by percutaneous inoculation, inhalation, as-
piration, or ingestion, and no vaccine targeting this organism is
available (2). In 2012, B. pseudomalleiwas reclassified by U.S. fed-
eral agencies as a tier 1 select agent, the highest risk category for a
biological entity, due to concerns that this bacteriumwould pose a
severe threat to humans and animals in the event of its deliberate
misuse (3).
TheB. pseudomallei genome exhibits high homologous recom-
bination rates. On a per-allele basis, recombination is estimated to
occur between 18 and 30 times more frequently than mutation
(4). This extensive lateral gene transfer can confound population
analyses, particularly those that are based on studying limited geo-
graphic regions (e.g., theNorthern Territory, Australia [5]) due to
high rates of homoplasy observed among genetic variants. In con-
trast, genomic analyses of B. pseudomallei populations on a con-
tinental scale have revealed a clear separation of B. pseudomallei
isolates betweenAsia andAustralia (4, 6, 7). Bayesian analysis ofB.
pseudomallei genome variation points to an ancient separation,
with migration out of Australia into Asia occurring tens of thou-
sands of years ago during the Pleistocene (4). The rarity of patho-
gen movement is due largely to one factor: new melioidosis cases
almost always result from bacterial infection acquired from the
local environment, with human-to-human and zoonotic trans-
mission of this pathogen being exceedingly rare (8). In support of
the rarity of B. pseudomallei movement across major biogeo-
graphic boundaries, the definitive transmission of B. pseudomallei
from Asia into Australia has not yet been observed. Nevertheless,
melioidosis cases imported into nonendemic locations via travel-
ers are being increasingly reported, as is recognition of locations
that are endemic for melioidosis outside the classical regions of
Southeast Asia and Australia (9). With modern global travel and
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commerce, the potential for long-range transmission and ecolog-
ical establishment of B. pseudomallei is increasing.
Lower-resolution genotyping methods, such as multilocus se-
quence typing (MLST) (10–13) and 16S internal transcribed
spacer typing (14), support the continental separation of B. pseu-
domallei observed on the genomic level (see, e.g., references 5 and
15), and these molecular tools have proven useful for source trac-
ing B. pseudomallei in regions that are nonendemic for the organ-
ism (14, 15). However, these genotyping methods have their lim-
itations, as evidenced by a recent study in which two multilocus
sequence types (STs) shared between Australia and Cambodia
were found to be genetically unrelated on the whole-genome level
(7). Thus, whole-genome sequencing (WGS) is essential for con-
firming the true geographic origin of B. pseudomallei strains.
Darwin, the capital city of the Northern Territory, Australia,
has an exceptionally high incidence of melioidosis (16), with pub-
lished rates paralleled only in northeastern Thailand (17). Since
October 1989, the Darwin ProspectiveMelioidosis Study (DPMS)
has documented all known melioidosis cases in Darwin and the
greater Top End region of the Northern Territory (18, 19). In
2001, we began undertaking environmental sampling in Darwin
to detect, characterize, and better understand the distribution of
B. pseudomallei in this region. In this study, we detail the unprec-
edented occurrence and rise in prevalence of an Asian B. pseu-
domallei clone, ST-562 (20), in the Darwin region. Prior to 2005,
this ST was not observed in Australia, with other STs (ST-36,
ST-109, and ST-132) being dominant in clinical, animal, and en-
vironmental isolates from this region. Surprisingly, ST-562 is now
themost common ST affectingmelioidosis patients in the Darwin
region, having surpassed the prevalence of ST-36, ST-109, and
ST-132 in the 2013-2014 northern Australian wet season.
MATERIALS AND METHODS
Ethics statement. Ethical approval for the DPMS was obtained through
the Human Research Ethics Committee of the Northern Territory De-
partment of Health andMenzies School of Health Research, approval no.
HREC 02/38 (“Clinical and epidemiological features of melioidosis”). All
patient data were deidentified prior to analysis.
Culturing, DNA extraction, and WGS. Human and animal B. pseu-
domallei isolates were initially subcultured from clinical specimens (ex-
cluding blood samples) using a combination of Ashdown’s broth and
subsequent plating onto Ashdown’s agar (Oxoid; Thebarton, South Aus-
tralia, Australia). Blood samples were incubated in blood culture bottles
until microbial growth was detected, and cultures were subsequently in-
cubated onto chocolate and horse blood agar under aerobic and anaerobic
conditions; B. pseudomallei was confirmed using the highly specific type
three secretion system I assay (21). Environmental samples from soil,
water, and air were cultured according to methods described elsewhere
(22, 23), with soil samples in the current study collected atmultiple depths
(10 cm, 15 cm, or 20 cm). For genomic DNA extraction, isolates were
subcultured once for purity on chocolate agar (Oxoid). The isolates were
grown under aerobic conditions at 37°C for 24 h prior to extraction. DNA
for PCR only was extracted using 5% Chelex 100, heat treated at 95°C for
20 min, and diluted 1:10 in molecular-grade H2O prior to PCR. DNA for
WGS was extracted as previously described (24), quality checked, and
quantified using the NanoDrop 2000 spectrophotometer (Thermo Fisher
Scientific, Scoresby, Victoria, Australia). Genomic data were generated
from paired-end Illumina reads using theHiSeq 2000 platform (Illumina,
Inc., San Diego, CA, USA). WGS was performed at Macrogen, Inc. (n
184; Geumcheon-gu, Seoul, Republic of Korea) or the Center for Micro-
bial Genetics and Genomics and Translational Genomics Research Insti-
tute (n 132; Flagstaff, AZ, USA).
Clinical isolates. For the 25 years fromOctober 1989 to August 2014,
888 melioidosis cases were enrolled in the DPMS. Of these, epidemiolog-
ical and clinical case history data have identified 473 (53.2%) cases that
were acquired in the Darwin urban region, the most densely populated
region and the capital city of the Northern Territory. This region encom-
passes approximately 300 km2 and extends east to the greater Palmerston
area, north to Buffalo Creek, and south to the Channel Island region. A
viable B. pseudomallei culture was not able to be obtained for 18 (3.8%) of
these clinical cases. All other isolates (n  455) are available and were
therefore examined in this study.
Environmental isolates. Since 2001, we have conducted environmen-
tal sampling of B. pseudomallei in the Darwin urban region as part of
ongoing surveillance and public health monitoring of this pathogen.
These sampling efforts have yielded 223 unique B. pseudomallei-positive
sites. All isolates were obtained from soil, with the exception of one isolate
from an air sample (23) and six from water (see Table S3 in the supple-
mental material).
Animal isolates.Wealso examined 17B. pseudomallei isolates from10
melioidosis-afflicted animals (sheep, cattle, camel, and parrot) that pre-
sented with melioidosis between 1993 and 2014. These animals were
housed in an area where ST-562 was identified in the environment.
MLST analyses. The B. pseudomallei MLST database (http:
//bpseudomallei.mlst.net/) currently harbors the greatest number of B.
pseudomallei strain genotypes from around the globe, making it a useful
tool for geographic attribution. As of 18 May 2015, this database con-
tained 1,092 unique STs among 3,649 submitted B. pseudomallei isolates.
Of these isolates, 3,283 isolates (90%) originate from either Asia or Aus-
tralia, constituting 1,020 STs. These 1,020 STs were analyzed by eBURST
(25) to determine the probable geographic origin of ST-562. A total of 521
(51%) STs were from Australia, 495 (49%) STs were from Asia, and 4 STs
(ST-89, ST-105, ST-562, and ST-849) were found in both regions. All
isolates from Bangladesh, Cambodia, China, Hong Kong, India, Indone-
sia, Laos, Malaysia, Pakistan, the Philippines, Singapore, Sri Lanka, Tai-
wan, Thailand, Vietnam, and Yap were included in the Asian group. To
simplify the analysis, only STs sharing 6 loci within group 1 (founder,
ST-48) were examined by eBURST.
MLST data have previously been generated for 398/455 clinical and
88/223 environmental isolates (see Table S3 in the supplementalmaterial)
from the Darwin urban region. Due to the high cost and labor-intensive
nature ofMLST, isolates lackingMLST data for this study were genotyped
using novel ST-specific single-nucleotide polymorphism (SNP) real-time
PCR assays targeting the four most common Darwin region STs (ST-36,
ST-109, ST-132, and ST-562), using the methods described below.
Genomic analyses. To identify ST-specific SNPs for ST-36, ST-109,
ST-132, and ST-562 and to identify the probable geographic origin of
ST-562, we performed comparative genomic analysis across a large B.
pseudomallei isolate data set. We used WGS data for 455 predominantly
AustralianB. pseudomallei isolates comprising 217 STs (see Table S2 in the
supplemental material). Additional autochthonous isolates from Brazil,
China, Malaysia, Pakistan, Papua New Guinea, Singapore, Thailand, and
Vietnam and an allochthonous isolate from a melioidosis case diagnosed
in Arizona, USA, were included in our analysis. WGS data were either
obtained from public databases (n  139) or generated in-house (n 
316). For publicly available genomes lacking Illumina data, synthetic
paired-end reads were generated with ART (version VanillaIceCream)
(26) using quality shift values of 10. The comparative genomics pipeline
SPANDx version 2.7 (27) was used to identify orthologous core-genome
biallelic SNPs among the 455 B. pseudomallei genomes using default pa-
rameters. The B. pseudomallei Thai strain K96243 (28) (GenBank acces-
sion numbers NC_006351 and NC_006351 for chromosomes 1 and 2,
respectively) was used as the reference genome for read mapping align-
ment. SNPs specific for ST-36, ST-109, ST-132, and ST-562 were identi-
fied initially from the SPANDx-generated SNP matrix (comprising
223,719 SNPs) using PLINK version 1.07 (29). The SNPs with the largest
distance separating them from other SNPs were preferentially chosen for
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assay design due to a decreased likelihood of recombination in these re-
gions and for increased probability of primer binding specificity. The
locus specificity for each ST SNP assay was confirmed with BLAST. The
Yersinia-like fimbrial (YLF) and Burkholderia thailandensis-like flagellum
and chemotaxis (BTFC) gene clusters were identified in silico using the
BEDCov presence/absence matrix generated by SPANDx.
In silico MLST was performed on all genome-sequenced isolates to
confirm ST assignments, and new isolate and ST data were uploaded
to the public B. pseudomallei MLST database.
To assess within-ST genomic diversity, each ST-36, ST-109, ST-132, and
ST-562 strain was analyzed against a reference genome of the same ST. The
publicly available genomes for B. pseudomallei MSHR0305 (GenBank
accession numbers NC_021884 and NC_021877) (30), MSHR4462
(GenBank accession no. JPQM00000000) (31), MSHR465J (GenBank ac-
cession no. JPZW00000000) (31), and MSHR5858 (GenBank accession
numbers CP008892 and CP008891) (32) were used as alignment refer-
ences for the ST-36, ST-109, ST-132, and ST-562 Illumina data, respec-
tively. In addition to the default SPANDx SNP filtering parameters (i.e.,
exclusion of SNPs in which 3 are found within 10 bp of each other),
phylogenetic reconstruction was also carried out using a heavy SNP re-
combination density filter (i.e., exclusion of SNPs for which2 are found
within 2 kb of each other) to mitigate the effects of recombination on
observed strain diversity (Table 1; see also Fig. S2 in the supplemental
material) (7, 33). The ST genome phylogenies used both SNP and in-
sertion-deletion (indel) variants to improve the epidemiological asso-
ciations, as we described elsewhere (5). Recombinogenic SNPs were
also identified using the default parameters in Gubbins (see Fig. S3 in
the supplemental material) (34).
ST SNP typing. Isolates lackingMLST data in our isolate data set were
screened with an inexpensive PCRmethod to determine their ST. Candi-
date SNPs specific for the four STs were converted to SYBR green-based
mismatch amplification mutation assays (SYBR MAMAs) (see Fig. S1 in
the supplemental material). We chose the SYBR MAMA format (also
known as allele-specific real-time PCR) due to its speed, simplicity, and
low cost (35, 36). The ST-specific primers are as follows, in 5= to 3= format
(lowercase bases indicate deliberate mismatches [36], and underlined
bases indicate the SNP position): ST36-only-T (CCGACGAGCCGACGt
GT), ST36-others-C (CGACGAGCCGACGtGC), and ST36-For (TCGT
GCGTGACGATGATGAC); ST109-only-T (GGTCCGCGAGCATCGa
CT), ST109-others-A (GTCCGCGAGCATCGaCA), and ST109-For (GG
CTTCTCCGTGCCGAAC); ST132-only-T (CGCAGGCCGCGATGtAT),
ST132-others-C (CGCAGGCCGCGATGtAC), and ST132-Rev (CGAGA
GCATCGTCTGGGACAC); and ST562-others-T (AACGAATATGTCGT
GACCGTcAT), ST562-only-C (AACGAATATGTCGTGACCGTcAC),
and ST562-Rev (GTGCCCTTGTCGAACAGYTAG).
To assess the accuracy of the four SYBRMAMAs, 139 B. pseudomallei
isolates with WGS data were screened across the ST SNP assays; all four
assays performed with 100% accuracy. The ST SNP assays were subse-
quently screened across all Darwin region isolates lacking MLST data.
Real-time PCRs were conducted in a 5-l total reaction volume in 384-
well optical PCR plates using 1 SYBR green PCR master mix (Applied
Biosystems, Foster City, CA, USA), primers at a concentration of 250 nM,
and molecular-grade water. Each allele-specific primer was paired with
the common primer and run as two separate reactions per ST assay. Ap-
propriate controls (target ST, nontarget ST, and no-template controls
[NTCs]) were included for each run to ensure accuracy. Thermocycling
was carried out using default parameters on the ABI Prism 7900HT in-
strument (Applied Biosystems); a dissociation curve was included at the
end of each run to ensure specificity. All samples were run in duplicate
using 1 l of DNA template.
Phylogenetic analysis. Maximum parsimony trees were generated
from relevant SPANDx .nex outputs using PAUP* 4.0b10 (37). For with-
in-ST genomic comparisons, SNP and small indel variantswere combined
for increased resolution and improved epidemiological signal (5). For the
455-genome phylogeny, bootstrapping using 100 replicates was per-
formed to determine the robustness of the relevant branches. Maximum-
likelihood trees were generated from the Gubbins analyses as part of the
Gubbins software (34).
Nucleotide sequence accession numbers. Illumina sequence data for
the 107 ST-36, ST-109, ST-132, and ST-562 B. pseudomallei genomes de-
scribed in this study have been deposited into the Sequence Read Archive
database under accession no. SRP065595. Other non-publicly available
genomes described in this study are available from the authors upon re-
quest.
RESULTS
MLST analyses suggest that ST-562 is Asian in origin. To inves-
tigate the likely origin of ST-562, we first performed a basic inter-
rogation of the B. pseudomalleiMLST database. Of the 46 ST-562
isolates deposited in the MLST database to date, 45 have been
epidemiologically linked to the Darwin region or have been re-
trieved from the Darwin environment, with one isolate from a
melioidosis patient inHainan, southernChina (see Table S1 in the
supplemental material). A search for ST-562 single-locus variants
(SLVs) (i.e., 6/7 MLST loci shared with ST-562) identified several
STs: ST-99, ST-167, ST-303, ST-388, ST-704, ST-1257, and ST-
1349. All isolates harboring these STs are Asian in origin, being
represented by clinical or environmental isolates from Cambo-
dia, China, Malaysia, the Philippines, and Thailand. Using less-
stringent criteria to identify ST-562 double-locus variants
(DLVs) (i.e., 5/7 loci shared with ST-562), we again failed to
find any Australian STs, although additional isolates from Ban-
gladesh, Kenya, Laos, Pakistan, Papua New Guinea, and Viet-
nam were found.
We next performed eBURST (25) analysis of the MLST data
from all available Asian andAustralian isolates (n 3,283 isolates;
1,020 STs) to determine the likely origin of the ST-562 clone.
eBURST is a popular tool for assessing and reconstructing the
evolutionary relatedness of bacterial strains with associatedMLST
data (25), although its accuracy is diminished in highly recombi-
nogenic species such as B. pseudomallei (7, 38). Nevertheless, this
tool can provide useful, albeit not definitive, phylogeographic in-
formation for this species. Although not conclusive, our eBURST
analysis demonstrated that ST-562 probably resides within an
Asian clade, as it grouped with other Asian STs and is well sepa-
rated from all Australian STs (Fig. 1).
Comparative genomic analysis confirms an Asian origin for
Australian ST-562.To conclusively identify the geographic origin
of the ST-562 clone found in northern Australia, we performed
additional WGS on 316 isolates comprising primarily Australian
B. pseudomallei (n 305) isolates. These datawere combinedwith
129 publicly available B. pseudomallei genomes representing
Asian, Australasian, and SouthAmerican isolates, for a total of 455
TABLE 1 Effect of genetic recombination on B. pseudomallei diversity in
ST-36, ST-109, ST-132, and ST-562a
ST
No. of
genomes
No. of SNPs after
default filter (3
SNPs within 10 bp)
No. of SNPs after
heavy filter (2
SNPs within 2 kb)
% SNPs
removed by
heavy filter
ST-36 28 379 297 22
ST-109 36 9,536 331 97
ST-132 21 615 99 84
ST-562 31 56 56 0
a SNP, single-nucleotide polymorphism. The default SNP density filter in SPANDx (27)
was compared with a stringent SNP density filter, which removes the majority of
recombinogenic SNPs.
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genomes (see Table S2 in the supplemental material). In addition
to the publicly available ST-562 genome (B. pseudomallei
MSHR5858), we included a further 31 ST-562 isolates from the
Darwin region.We also sequenced several ST-36 (n 28), ST-109
(n 36), and ST-132 (n 21) isolates to enable a comparison of
ST-562 with these other common STs from the Darwin region.
Despite high levels of recombination in B. pseudomallei, phyloge-
netic reconstruction of the 223,719 SNPs identified robust clus-
tering of STs into distinct phylogeographic clades and confirmed
that ST-562 definitively falls within the Asian clade (Fig. 2). All
other Australian genomes fell into the Australian clade.
The genomic data were also used to determine the distribution
of the mutually exclusive BTFC/YLF gene clusters (39) in the 455
B. pseudomallei strains in silico. The BTFC cluster is common in
Australian strains (between 79 and 88% in other published studies
[39, 40] and 65% in our data set), whereas Asian strains almost
exclusively carry YLF, as evidenced by 30/31 (97%) of the Asian
genomes in our data set containing YLF (see Table S2 in the sup-
plemental material). The ST-562 strains all harbored YLF, adding
further weight to the hypothesis of an Asian origin for these
strains.
ST-562 emergence in Darwin melioidosis cases. ST profiles
for our isolates were first determined using eitherMLST or, where
MLST data were lacking, SYBR MAMA PCR assays, which were
developed as part of the current study to aid in the rapid and
inexpensive detection of ST-36, ST-109, ST-132, and ST-562 (see
Fig. S1 in the supplemental material). Of the 455 clinical isolates
collected from melioidosis patients in the Darwin region since
1989, 40% have been attributed to four common STs: 49 cases
(11%), 71 cases (16%), 40 cases (9%), and 28 cases (4%) were
attributed to ST-36, ST-109, ST-132, and ST-562, respectively.
These STs are less common outside the Darwin region (5), and
ST-562 has not been identified in other Australian locales. The
first clinical ST-562 isolate, B. pseudomallei MSHR1967, was ob-
served in a single case during the 2004-2005 northern Australian
wet season, with the next case observed in the 2006-2007 wet sea-
son. All subsequent cases occurred during or after the 2008-2009
wet season. The number of melioidosis cases attributable to infec-
tion with the ST-562 clone has risen dramatically since the 2008-
2009 season (Fig. 3), and in the 2013-2014 wet season, ST-562 was
identified in 9/34 (26%) Darwin clinical cases, the highest per-
centage seen to date. In contrast, the numbers of cases caused by
ST-36, ST-109, and ST-132 during that period were only 4 (12%),
4 (12%), and 2 (6%), respectively.
Environmental ST-562 in Darwin is geographically re-
stricted. Since 2001, we have conducted environmental sampling
of B. pseudomallei in the Darwin urban region as part of the on-
going surveillance and public health monitoring of this pathogen.
We were therefore able to investigate the environmental distribu-
tion of this ST in the Darwin region over time. Of 223 B. pseu-
domallei-positive environmental samples, just two (soil sample
MCAPS118B and air sample ASDA11A) harbored ST-562. Both
samples were obtained during a squally rain storm from the same
site on the same day in 2011 (23). Five other B. pseudomallei-
positive environmental samples from this suburb, whichwere col-
lected in earlier wet seasons, were ST-109. No additional environ-
mental samples have been collected in this suburb since 2011. In
contrast, we have identified 37 ST-36-positive samples, 62 ST-
109-positive samples, and 13 ST-132-positive samples in the Dar-
win region since the 2001-2002 wet season (see Table S3 in the
supplemental material).
Emergence of ST-562 in Darwin animal melioidosis cases.
We examined 17 B. pseudomallei isolates from 10 melioidosis-
afflicted animals (sheep, cattle, camel, and parrot) that pre-
sented with melioidosis between 1993 and 2014. These animals
were all housed in the suburb where ST-562 was identified in
the environment. The two most recently afflicted animals,
which were diagnosed with melioidosis in 2009 and 2014, were
both infected with ST-562. In contrast, the other eight animals
were diagnosed in 2005 or earlier, and none were infected by
ST-562.
Genomic comparison of ST-562with other commonDarwin
STs. Genomic analysis of ST-36, ST-109, ST-132, and ST-562
isolates was used to provide a measure of comparative genetic
FIG 1 eBURST analysis of Australian and Asian B. pseudomallei sequence types (STs). Red highlighting indicates Australian isolates, no shading indicates Asian
isolates, and purple shading indicates STs that overlap between Australia and Asia. All other colors were generated by the eBURST program and are explained
elsewhere (25). One overlapping ST, ST-89, was not included in this diagram, as explained in Materials and Methods. This analysis hints that ST-562 might be
Asian in origin.
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diversity among the Australian ST-562 isolates. Using default
SNP density filtering parameters in SPANDx (27), ST-109 was
found to be the most diverse ST, with 9,536 SNPs and 211 kb
(3%) of the 7.3-Mbp MSHR4462 reference genome being
variably present among the 36 genomes (Table 1). ST-36 and
ST-132 were less diverse, with 379 and 615 SNPs identified in
28 and 21 genomes, respectively, and 119 kb and 62 kb of the
genome being variably present among these ST genomes, re-
spectively. In comparison, we identified only 56 SNPs among
the 31 ST-562 isolates. However, 127 kb of the genome was
variably present among the ST-562 isolates, approximately
double the amount of locus variation seen in ST-132 (see Fig.
S2 in the supplemental material). One ST-562 strain, B. pseu-
domalleiMSHR8014, had an89-kb deletion, and another strain,
B. pseudomallei MSHR8055, had a separate 10-kb deletion,
which accounted for most of the locus variation in the Australian
ST-562 isolates.
Given that recombinationmay lead to artificially high diversity
measurements, we explored the role of recombination on ST-36,
ST-109, ST-132, and ST-562 SNP diversity. Using heavy SNP den-
sity filtering to remove recombined regions, the proportion of
SNPs in ST-36, ST-109, and ST-132 decreased by between 22%
and 97%, whereas that of ST-562 did not change (Table 1; see also
Fig. S2 in the supplemental material). ST-132 strains still had ap-
FIG 2 Pinpointing the geographic origin of ST-562 using phylogenetic analysis of 455 B. pseudomallei genomes.Maximum parsimony phylogenetic reconstruc-
tion using 223,719 core-genome orthologous SNPs demonstrates that B. pseudomallei possesses a strong phylogeographic signal on the whole-genome level,
despite very high levels of recombination. ST-562 isolates retrieved frommelioidosis cases and the environment in Darwin, Australia, cluster with Asian isolates.
No other Australian STs (n 191) cluster with Asian strains. This analysis also confirms that identical STs cluster together (gray shading) with high confidence.
SNPs specific for the four target STs (ST-36, ST-109, ST-132, and ST-562) were identified from the core-genome orthologous SNP output and were used for
ST-specific assay design. The overall tree consistency index (CI)was 0.15, and the ST-562 subcladeCIwas 0.93 (see Fig. S2 in the supplementalmaterial). Relevant
bootstrap values are shown.
Price et al.
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proximately twice the number of SNPs as ST-562, and ST-36 and
ST-109 had approximately five and six times more SNPs than
ST-562, respectively (Table 1). Gubbins analysis also identified
recombinogenic SNPs among the ST-36, ST-109, and ST-132 ge-
nomes, but none were found in ST-562 (see Fig. S3 in the supple-
mental material).
DISCUSSION
In this study, we confirmed the unprecedented transmission of
the pathogenic bacterium B. pseudomallei from one region en-
demic for the pathogen to another, in this case, from Asia to Aus-
tralia. Unlike most other human pathogens, B. pseudomallei al-
most always causes infection through contact with contaminated
soil or water, with only a small number of zoonotic, nosocomial,
or human-to-human cases reported in the literature (e.g., refer-
ence 41). Therefore, the use of high-resolution molecular tools in
combination with epidemiological data provides a robust and
powerful way to identify the geographic origin of a given B. pseu-
domallei infection. Here, we used MLST-, WGS-, and PCR-based
methods to identify the presence of an Asian B. pseudomallei
clone, ST-562, in several clinical, animal, and environmental iso-
lates from northern Australia. ST-562 was not detected in Austra-
lia prior to 2005, pointing to an emerging clone with recent trans-
mission into northern Australia from Southeast Asia.
Although very infrequent, the transmission of B. pseudomal-
lei across major geographic barriers has been a necessary occur-
rence for the global dispersal of this bacterium. In 2009, Pearson
and colleagues (4) usedWGS of 43 Burkholderia spp. to show that
B. pseudomallei likely originated in Australia, followed by one of
more rare dissemination events into Southeast Asia across the
Wallace Line sometime between 16,000 and 225,000 years ago.
The Wallace Line is a major biogeographic barrier between Asia
and Australia that has led to restricted genetic flow among the
flora and fauna between these two regions. Other studies have
since affirmed the ancestral nature of Australian B. pseudomallei
and the rare historical transmission of B. pseudomallei from Aus-
tralia to Asia (6, 15). The ancient separation of these two popula-
tions has enabled a strong phylogeographic signal between Asian
and Australian clades to evolve despite high levels of recombina-
tion across the B. pseudomallei genome (4, 6). The clarity of this
geographic signal is a consequence of both localized evolution and
the rarity of transmission, and thus gene flow, between B. pseu-
domallei strains from these regions.
The generation of substantially more B. pseudomallei
genomic data in recent years has enabled us to increase the reso-
lution of the phylogeny first presented by Pearson et al. (4) by
10-fold. In the current study, we reconstructed a midpoint-
rooted maximum parsimony phylogeny using 223,719 core-ge-
nome orthologous SNPs identified across 455 global B. pseu-
domallei genomes from Australia, Brazil, Papua New Guinea,
Southeast Asia, and South Asia (Fig. 2). This tree represents the
most extensive and in-depth global phylogeny of B. pseudomallei
constructed to date. Like Pearson and colleagues, we noted a
strong geographic signal whereby Australian strains were phylo-
genetically distinct from Asian and Brazilian strains, with the ex-
ception of ST-562, an emerging clone in northern Australia that
unequivocally grouped with Asian strains. MLST analysis of 3,283
Australian and Asian isolates supported our WGS findings (Fig.
1), with all SLVs and DLVs of ST-562 being Asian in origin.
In further support of an Asian origin for ST-562, this ST was
recently documented in clinical isolates fromHainan, southern
China (20), and in clinical and environmental isolates from the
Er Ren Basin region of southern Taiwan (42). Three of 110
melioidosis cases diagnosed between 2008 and 2012 in Hainan,
the southernmost province of China, were identified as ST-562
(20). ST-562 has also been reported in an unpublished clinical
case from Hainan (BPC003; identification [ID] 3875; http:
//bpseudomallei.mlst.net). In the Er Ren Basin, 15/59 (25%) B.
pseudomallei-positive soil samples collected between 2005 and
2007 and 2/194 (1%) clinical cases from this region diagnosed
between 2004 and 2010 were identified as ST-562 (42). Interest-
ingly, two different pulsed-field gel electrophoresis (PFGE) types
were identified among environmental and clinical Taiwanese ST-
562 isolates (42), pointing to ST-562 genetic diversity in this re-
gion and thus a possible ancestral origin for ST-562 in Taiwan.
We initially used MLST to determine the probable origin of
ST-562, as the MLST database has the greatest abundance of
data for global B. pseudomallei strains. In addition to ST-562, the
global MLST data set contains three other instances of B. pseu-
domallei ST overlap between Asia and Australia: ST-89, ST-105,
and ST-849 (Fig. 1). It was recently demonstrated that ST-105 and
ST-849, which have each been observed in both Australian and
Cambodian B. pseudomallei isolates, are in fact phylogeographi-
cally distinct on a whole-genome level. The isolates from Cambo-
dia with these shared STs are not genetically related to the isolates
FIG 3 Incidence of melioidosis cases in the Darwin region attributed to common STs since 1990. The Asian clone, ST-562, has increased in prevalence
in this region relative to the three other common STs since the first case was identified in 2005. In the 2013-2014 season, ST-562 was, for the first time, the
most common ST isolated from melioidosis cases in the Darwin region.
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of the same ST from Australia but rather are the result of ho-
moplasy (7). Less clear is the ST-89 overlap, which has been de-
scribed in aB. pseudomallei isolate fromamelioidosis patient from
the Torres Strait Islands of Australia and in a Thai environmental
isolate (43). Further review of the strains involved suggests that
incorrect provenance likely accounts for this overlap, with the
ST-89 strain listed as being fromThailand,while it ismore likely to
actually be an Australian strain (44). Unlike the ST-89 overlap,
ST-562 has compelling genetic and genomic data linking the ori-
gin of this clone to Asia. Therefore, ST-562 is the only confirmed
B. pseudomallei clone thus far that has been definitively docu-
mented in both Asia and Australia.
The detection of ST-562 in northern Australian melioidosis
cases is of concern for several reasons, not least of which is the
higher melioidosis mortality rate in Asia (2), which may in part
be attributable to heightened infectivity or virulence potential
of Asian strains (40). Of the 455 melioidosis cases identified
between October 1989 and August 2014 that have been epide-
miologically linked to the Darwin region, 28 were caused by
ST-562. We observed a dramatic spike in ST-562 incidence,
particularly during the 2013-2014 northern Australian wet sea-
son (see Table S1 and Fig. 3 in the supplemental material),
which, for the first time, surpassed the proportion of cases
caused by other common Darwin STs (ST-36, ST-109, and ST-
132). The incidence of ST-562 began to rise in the 2008-2009
wet season and has steadily increased since then (Fig. 3). Al-
though the reason for this increase is unclear, above-average
rainfall in the Top End in the 2009-2010 wet season, a region
which saw an unprecedented number of melioidosis cases (16),
may have contributed to ST-562 dissemination due to higher
water levels and erosion and thus greater exposure risk. Al-
though we did not investigate this possibility in our study,
ST-562 may possess an adaptive advantage that enables this
clone to survive, persist, and even flourish in the northern Aus-
tralian environment, thereby outcompeting other strains. The
increase in ST-562 prevalence is alarming, as it suggests that
cases caused by this emerging clone are on the rise in this area,
with the possibility of elevated melioidosis mortality rates in
future years should ST-562 be confirmed to be more virulent
than the other common Darwin STs. Further data over the
upcoming northern Australian wet seasons will be essential for
investigating these possibilities.
To confirm the in situ presence of ST-562 in the northern
Australian environment and to rule out infection acquisition
following travel to Asia, we conducted a complete survey of all
B. pseudomallei-positive environmental samples collected in the
Darwin region since 2001, the year our environmental sampling
efforts began. An analysis of 223 unique samples identified just
two ST-562-positive samples (one soil and one air), which were
collected from the same urban site in 2011 (23). The very low
ST-562 environmental detection rate is in contrast to the detec-
tion rate of the other common Darwin STs, which are readily
isolated from the environment across the Darwin region (see Ta-
ble S3 in the supplemental material). In combination with its
lower genomic variation compared to that of other Darwin STs
(Table 1; see also Fig. S2 and S3 in the supplemental material), our
findings indicate that the Australian ST-562 clone is not yet wide-
spread in the Darwin environment, although more detailed sam-
pling efforts are needed to confirm this hypothesis. None of our
patients had a history of travel to Asia, and the detection of ST-562
in the environment in the Darwin region provides support for a
locally acquired source of infection for all cases. The identification
of animals housed in the Darwin region that were infected with
ST-562 (see Table S1 in the supplemental material) further ce-
ments the autochthonous nature of ST-562 in Darwin.
The limited geographic focus of ST-562 clinical cases is also
strongly suggestive of a recent point-source introduction into
the Darwin region. To investigate further, we performed com-
parative genomic analysis on 32 ST-562 isolates, three of which
were environmental (including 2 colonies from the same pos-
itive soil sample) and the remainder clinical. This analysis re-
vealed that there is some diversity among ST-562 isolates on
the genome level, but this diversity is lower than that observed
among ST-36, ST-109, and ST-132, even when SNPs within
putative regions of recombination were omitted (see Fig. S2
and S3 in the supplemental material). Curiously, removal of
the recombinogenic SNP loci decreased the number of SNPs
identified among ST-36, ST-109, and ST-132 by between 22%
and 97% but did not affect ST-562, for which no SNPs were
removed by this filter (Table 1). This finding suggests that there
has been insufficient time for recombination to shape the ge-
nome of Darwin ST-562 B. pseudomallei, and it supports our
hypothesis of a recent introduction of ST-562 into northern Aus-
tralia.However, it cannot be ruled out that this clonemayundergo
recombination events less frequently in the northern Australian
environment than other Australian strains due to genetic distance
between ST-562 and potential donor strains, a phenomenon re-
cently reported by Nandi and coworkers (45). Alternatively, ST-
562 may exist in an ecological niche not shared by other B. pseu-
domallei strains, restricting opportunities for recombination. This
hypothesis is supported by a lack of other STs being isolated from
the two ST-562-positive environmental samples (see Table S3 in
the supplemental material). However, the absence of other STs in
environmental samples is not in itself uncommon (data not
shown), and sampling and microbiological processing biases can
be expected to greatly influence the cultivable B. pseudomallei
population of any specimen. Nevertheless, based on the compar-
ative genomic findings, a recent introduction of ST-562 remains
the most plausible scenario.
The precise route and date of the ST-562 introduction into
northern Australia remain speculative, as there are several un-
knowns. What is known is that the ST-562 clone has been in
Australia at least since 2005, when the first clinical case was
identified, and the geographic distribution of ST-562 appears
to be limited. Unfortunately, molecular clock modeling is un-
likely to provide useful dating information of the Australian
ST-562 clone for several reasons. First, putative restricted gene
flow between ST-562 and Australian strains (45), coupled with
high rates of recombination (4) in other strains, will dramati-
cally influence the projected rates of genetic diversity. Second,
there are no data on generation times or mutation rates in
environmental B. pseudomallei strains, with evolution and dou-
bling rates likely to vastly differ from those of in vitro- or mam-
malian-passaged strains. This issue of different generation times
has recently been exemplified in an outbreak of Francisella tular-
ensis (tularemia) in Sweden, where no correlations between spa-
tial, temporal, and genetic distances were found (46). Third, there
is insufficient resolution among the Australian ST-562 genomes,
as evidenced by several polytomies in our ST-562 phylogenies (see
Price et al.
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Fig. S2 and S3 in the supplemental material), which may be a
consequence of insufficient elapsed time since the introduction of
ST-562 into Australia. WGS of Chinese and Taiwanese ST-562
strains will likely provide critical clues as to the timing of ST-562
introduction into Australia and may help resolve some of these
existing molecular clock modeling issues.
Based on previous B. pseudomallei studies, we hypothesize
several scenarios of ST-562 transmission to Australia. The first
involves importation via environmental seeding from B. pseu-
domallei-infected animals, similarly to the devastating Parisian
zoo outbreak in the 1970s (47). Despite its strict quarantine legis-
lation, Australia does have a history of importing melioidosis-
susceptible exotic animals from Asia (e.g., the introduction of
Camelus spp. into Australia during the 1800s). As with humans
(19), animals can be infected with B. pseudomallei but not display
overt symptoms. Environmental seeding may have also occurred
from B. pseudomallei being shed from a chronically infected hu-
man (e.g., via expectoration) returning or traveling from Asia at
some stage in the past, or from the fecal matter of B. pseudomallei-
infected migratory or storm-driven birds flying south from Asia.
B. pseudomallei carriage and infection have been documented in
both native Australian and imported avian species and represent a
possible route by which B. pseudomallei was introduced into New
Caledonia and other Pacific islands from the Australian mainland
(48). Coastal northern Australia is a stop-off point for some of the
great migratory flyways, and shorebirds that have transited Asia
on their southern migration from Siberia to Australia have been
found to carry avian influenza viruses (49). The second scenario
involves the inadvertent importation of B. pseudomallei-contam-
inated plant or soil material. B. pseudomallei can infect the rhizo-
sphere, roots, and aerial parts of certain grasses, including exotic
species (50). However, imported soil was ruled out as a source of
B. pseudomallei infection in a highly unusual southern Arizonan
melioidosis case (14); in addition, the high salinity of potting mix
is not conducive to B. pseudomallei survival (51). A third scenario
is that ST-562 has been in the northern Australian environment
for several decades, or perhaps centuries, but has only recently
been uncovered by anthropogenically driven environmental dis-
turbances in the fast-growing Darwin region (51). A final possi-
bility is importation via B. pseudomallei-contaminated medical
products manufactured in Southeast Asia (19, 52); however, the
environmental detection of ST-562 B. pseudomallei, the occur-
rence of animal cases, and epidemiological investigation of human
cases render this scenario improbable. Ongoing investigation of
ST-562 from both Australia and Asia will be essential for identify-
ing the most probable transmission event/s into Australia.
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